DIRS.INFO The most relevant business & tech news

We're initiating a position in GE Healthcare (GEHC), buying 325 shares at roughly $79 each. GE Healthcare is the global leader in medical imaging, diagnostics, and digital solutions. GE Healthcare is one of the global leaders in Precision Diagnostics with an industry-leading injectable pharmaceutical portfolio in contrast media and molecular imaging. GE Healthcare is one of a few companies that offer a full suite of products and solutions to support patients. GEHC YTD mountain GE Healthcare YTD performance Analysts see GE Healthcare growing EPS to $4.33 in 2024, about a 15% increase from this year's outlook.

☆ See the 19-slide presentation that got General Catalyst to back a startup tackling a $25 billion problem for hospitals
▼ + stars: | 2023-05-17 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +3 min

The startup used this pitch deck to get backing from top healthcare VC firm General Catalyst. The Magoons' new startup, Adonis, raised $5.6 million in seed funding in October to solve that problem with tech. Just under seven months later, Adonis has raised $17.3 million more in Series A funding, led by top healthcare VC firm General Catalyst. "Given all the work we do with health systems, we know how complicated and poorly organized these systems are, despite all the money they're collecting," she said. Check out the pitch deck Adonis used to get $17.3 million led by General Catalyst.

☆ The pharmacy that quietly powered top startups in the hottest part of healthcare is trying to reinvent itself after losing customers and closing facilities
▼ + stars: | 2023-05-15 | by ( Rebecca Torrence | Blake Dodge | ) www.businessinsider.com time to read: +10 min

"We were shocked," a former employee in Truepill's business development division said of the layoffs. Insider spoke with five former and two current Truepill employees about the challenges the company is confronting after a tumultuous year. Truepill was hiring employees rapidly, accumulating about 1,800 employees by the spring of 2022, according to one former employee in Truepill's business division. Since then, there's been a companywide push to inch closer to profitability, one of the current employees told Insider. It's also downsizing its Miami pharmacy, the current employee said.

☆ Billionaires and CEOs descended on Beverly Hills to talk recession, bank failures, and more. Here's the inside track.
▼ + stars: | 2023-05-07 | by ( Matt Turner | ) www.businessinsider.com time to read: +4 min

On the agenda today:But first: The big takeaways from the Milken Institute Global Conference in Beverly Hills. Senator Joe Manchin (D-WV) speaks at the 2023 Milken Institute Global Conference Mike Blake/ReutersThe big-money set jetted into LA last week for the Milken Global Conference. Biggest opportunityCampbell: The pullback in lending by banks is raising the hopes of those in the private credit industry. Read more:'Junk fees'Getty ImagesIt goes by many names: an administrative fee, a transaction fee, even a "regulatory compliance" fee. Akash Nigam, the founder and CEO of Genies, who is spending $2,400 a month on ChatGPT accounts for all his employees.

☆ See the pitch deck a Wharton grad used to raise $30 million to tackle one of healthcare's most expensive problems
▼ + stars: | 2023-04-26 | by ( Yeji Jesse Lee | ) www.businessinsider.com time to read: +2 min

Digestive health issues are common and costly to treat. The startup said this month that it raised $30 million from investors to scale its platform. Earlier this month, Oshi announced that it raised a $30 million Series B round led by Koch Disruptive Technologies. Oshi Health removed financial details from the pitch deck it used to raise $30 million in Series B before sharing the presentation with Insider. See the presentation Oshi Health used to raise $30 million:

☆ The 13 startups to watch in the $100 billion market for buzzy new weight-loss drugs like Ozempic
▼ + stars: | 2023-04-11 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +3 min

Healthcare startups are launching to prescribe weight-loss drugs such as Ozempic. They're chasing what's projected to be a $100 billion market for the drugs. Venture-backed health startups are vying for a piece of the booming market for new prescription drugs designed to help with weight loss. Many startups offering weight-loss drugs have flooded social media platforms with ads for the shots. Insider rounded up 13 venture-backed startups competing for customers in the lucrative GLP-1 weight-loss market, listed from least to most funding raised.

☆ 13 startups vying for a slice of the $100 billion market for buzzy new weight-loss drugs
▼ + stars: | 2023-04-05 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +3 min

☆ See the pitch deck Zus Health used to convince top VCs like Andreessen Horowitz, F-Prime, and Maverick to back its solution for healthcare's $140 billion data-sharing problem
▼ + stars: | 2023-03-16 | by ( Blake Dodge | Rebecca Torrence | ) www.businessinsider.com time to read: +3 min

Zus Health launched in 2021 with $34 million from investors including Andreessen Horowitz, F-Prime Capital, Maverick Ventures, and Rock Health. Bush, Zus' CEO, told investors in a pitch, per a video Bush sent to Insider. Bush told Insider he was "blessed" to have his stake in the company diluted in this fashion, given the funding climate. "There's all these little pieces, but all of them are just re-clipboarding because nobody has a common clinical story," Bush told investors. Here's the deck Zus used to raise $40 million from Andreessen Horowitz, F-Prime Capital, Maverick Ventures, and Jazz Venture Partners.

☆ States and healthcare organizations join forces to help people prepare for Medicaid redeterminations
▼ + stars: | 2023-03-06 | by ( Sponsor Post | Created Insider Studios With Unitedhealthcare | ) www.businessinsider.com time to read: +6 min

As many as 18 million Americans may lose Medicaid coverage this year. Over the past three years, Medicaid recipients remained eligible thanks to a Congressional bill that provided funds to maintain continuous Medicaid coverage. But this April marks the end of this pandemic-era policy that helped people maintain their Medicaid coverage. That means the continuous enrollment provision will expire and states will return to their pre-pandemic policies of requiring people to renew their Medicaid coverage annually. Any individuals or families who lose Medicaid coverage through this redetermination process will need assistance securing replacement health insurance coverage.

☆ Wall St Week Ahead Defensives may not be safe place to hide as stock market stumbles
▼ + stars: | 2023-03-03 | by ( Lewis Krauskopf | ) www.reuters.com time to read: +5 min

"Last year it was really easy to hide out in defensives," said Anthony Saglimbene, chief market strategist at Ameriprise Financial. When compounded by the fact that some defensive stocks carry relatively expensive valuations, investors may avoid them even if the broader market sours. The S&P 500 was last up 3.7% in 2023, but had pulled back since posting its best January performance since 2019. However the sector's financial prospects this year are relatively weak; S&P 500 healthcare earnings are expected to fall 8.3% against a 1.7% increase for the overall S&P 500, according to Refinitiv IBES. Should concerns about recession spike, as they did last year, defensives could outperform again on a relative basis, according to investors.

☆ Wall St Week Ahead: Defensives may not be safe place to hide as stock market stumbles
▼ + stars: | 2023-03-03 | by ( Lewis Krauskopf | ) www.reuters.com time to read: +5 min

☆ Goldman sees another robust year for spinoffs. How to spot those that will outperform
▼ + stars: | 2023-02-21 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +5 min

In a research note published last week, Kostin updated that study to look at the track records of more recent spinoffs, completed over the past two years. "However, while 11 of the 20 spinoffs completed during 2022 outperformed the S & P 500 since transaction completion, only six of the spinoffs outperformed their parent entities." The largest completed deal in 2022 was General Electric' s spin off of GE HealthCare , a $26 billion business. The next largest completed deal last year was Intel's spinoff of Mobileye , which wrapped up on Oct. 26, 2022 . In 2021, the value of the completed spinoffs hit $112 billion, and included Dell's spinoff of VMWare , the largest deal at $57 billion.

☆ Digital health's funding slump isn't a death sentence. Here's what startups are doing to stand out to investors.
▼ + stars: | 2023-02-13 | by ( Rebecca Torrence | Blake Dodge | ) www.businessinsider.com time to read: +5 min

It's getting harder for digital-health startups to get investor attention. Fewer digital-health startups are fundraising, and the ones that are will be held to higher standards than before, investors told Insider. This year, a smaller group of digital-health startups is beginning to stand out. "It's been amazing to watch what this business has accomplished," she told Insider. Quantum is already earning enough to fund itself, Zane Burke, the CEO of Quantum, told Insider.

☆ Here's a look at 14 fintech startups that are tackling healthcare's money problems
▼ + stars: | 2023-02-13 | by ( Samantha Stokes | ) www.businessinsider.com time to read: +2 min

A new wave of startups are tackling financial issues within the healthcare space. Here are 14 fintech-healthtech startups that have raised money from VCs. "If you're thinking about building fintech that really helps the average consumer, a big piece of the wallet is healthcare spend," she told Insider in an interview. From the employee-benefits platform Budgie to the wellness credit card Ness, Insider has compiled a list of startups building at the intersection of fintech and healthtech. Check out Insider's list of 14 startups at the intersection of fintech and healthtech.

☆ Tenet Healthcare's fourth-quarter beat puts 2023 concerns at bay
▼ + stars: | 2023-02-09 | by ( ) www.reuters.com time to read: +2 min

Feb 9 (Reuters) - Tenet Healthcare Corp (THC.N) on Thursday beat Wall Street estimates for fourth-quarter results as growth in its outpatient service business put concerns around the hospital operator's weak 2023 forecast at bay. HCA Healthcare also recently forecast lower-than-expected 2023 profit, but bet on improved staffing trends and lower labor costs to drive growth for the year. "As expected, the 2023 forecast came in below consensus estimates, but we believe investors had already priced that in," SVB Securities analyst Whit Mayo said. Tenet is betting on growth in its ambulatory care unit, which deals with patients who are not bedridden and don't require overnight hospitalization. On an adjusted basis, Tenet reported a net income of $1.96 per share for the quarter ended Dec. 31, beating estimates of $1.23 per share.

☆ Alignment Healthcare's CEO shared 3 reasons he thinks the upstart will win in health insurance — and why it won't unravel like Bright Health
▼ + stars: | 2023-02-07 | by ( ) www.businessinsider.com time to read: +5 min

Young health insurers that went public in 2021 have bled money. Some health insurers that went public in 2021 at high valuations have struggled since then. Several young insurers have bled money as they've grown quickly. Bright Health, another Medicare Advantage insurer, came close to insolvency and had to shut down its health plans on the Affordable Care Act marketplace. Growing steadily with a narrow focusBefore the recent market slowdown, growing fast had been a common strategy for newly public health insurers and digital health broadly.

☆ Ex-Sheetz worker said she quit her job over the chain's 'smile policy' that bans 'obvious missing, broken or badly discolored teeth'
▼ + stars: | 2023-01-31 | by ( Alex Bitter | ) www.businessinsider.com time to read: +6 min

A former Sheetz employee said she quit over the chain's "smile policy." One employee said a manager referenced the 'smile policy' during a promotion discussionSome Sheetz employees refer to the chain's rule about teeth as the "smile policy." Managers have in some cases hired workers who technically violated the rule, however, workers told Insider. It covers half the cost of more complicated procedures, such as crowns, inlays, and denture repair, Sheetz told Insider. The same year, the company also increased its annual college tuition reimbursement amount to $5,250, up from $1,500, Sheetz told Insider.

☆ Stocks making the biggest moves midday: Carvana, Colgate-Palmolive, Tesla and more
▼ + stars: | 2023-01-30 | by ( Pia Singh | ) www.cnbc.com time to read: +2 min

Tesla — Shares dropped 2.8% after Berenberg lowered its earnings estimate for Tesla by around 25% for 2023 following the company's price cuts for its electric vehicles. Ford Motor Company — Shares fell nearly 1.4% after the company announced price cuts for its electric Mustang Mach-E crossover. The move in Ford comes after Tesla said earlier this month it would trim prices to counteract dwindling demand. AMC Entertainment — Common shares of the theater chain fell by more than 7% after AMC announced a shareholder meeting in March for a potential change to its capital structure. The preferred or "APE" shares, which trade at a large discount to the common shares, jumped by more than 16%.

☆ China's Covid wave drives up consumer interest in insurance after health system shortfalls
▼ + stars: | 2023-01-26 | by ( Evelyn Cheng | ) www.cnbc.com time to read: +7 min

For people planning to spend more on that health category, 47% said in December they intend to spend more on health insurance. "This experience is also driving increased interest in commercial health insurance which could cover access to premium private providers," Lipson said. Anecdotes depict a public health system overwhelmed with people at the height of the wave, and long wait times for ambulances. Some of the players in China's health insurance industry include Ping An , PICC and AIA . Hospital fundingHowever, one of the barriers to improving China's public health system is its fragmented financing system, according to Qingyue Meng, executive director at Peking University's China Center for Health Development Studies.

☆ EQRx promised to deliver cutting-edge drugs at half the cost of rivals. A cofounder shares why the once buzzy biotech is walking away from that mission
▼ + stars: | 2023-01-19 | by ( Andrew Dunn | ) www.businessinsider.com time to read: +5 min

After years of touting the idea of radically lower drug prices, EQRx has walked away from that plan. Cofounder Alexis Borisy said it was due to the FDA not OK'ing drugs based only on Chinese data. EQRx suddenly sounded like a typical biotech company, talking of "market-based pricing" that would "maximize value for shareholders." EQRx's stock is down over 75% since its record-breaking SPACAlexis Borisy, EQRx Chairman, and CEO Melanie Nallicheri. An unclear future for 'radically lower drug prices'EQRx CEO Melanie Nallicheri EQRxIn November, EQRx said it wouldn't pursue radically lower pricing for its first two drug candidates, both cancer therapies.

☆ Investors will stop rewarding digital health startups masquerading as tech companies in 2023, VC Aike Ho predicts
▼ + stars: | 2022-12-29 | by ( Blake Dodge | ) www.businessinsider.com time to read: +4 min

Many digital-health startups enjoy tech valuations without differentiated technology. As record investment has flowed into care startups, many of them have enjoyed valuations that mirror those of tech companies. In 2023, thanks in part to the struggling economy, Ho predicts that digital-health investing will stop rewarding this approach and favor startups with true technology differentiation. Ho said it's the right time for real technology startups to take off in healthcare. She's looking for founding teams with three distinct superpowers: understanding the healthcare landscape, understanding the technology behind products, and understanding that technology's clinical application.

☆ 4 hurdles Walmart needs to clear in 2023
▼ + stars: | 2022-12-24 | by ( Ben Tobin | ) www.businessinsider.com time to read: +6 min

Analysts expect the retailer to work through excess inventory in 2023, but obstacles may arise. Here are four major Walmart challenges to watch in 2023. Expanding clinic presence is a 'must' to create major healthcare gainsA Walmart Health clinic. In 2022, Walmart saw competitors like Amazon make major healthcare splashes. Part of expansion has been announced for 2023, as Walmart plans to launch 16 more clinics in Florida by the end of the year.

☆ Here are the 34 tech companies most likely to be snapped up by private equity firms like Vista and Thoma Bravo in 2023, according to bankers and market data
▼ + stars: | 2022-12-24 | by ( Ben Bergman | Stephanie Palazzolo | ) www.businessinsider.com time to read: +22 min

With a stock price down 45% in the last year, though, it may soon find itself on the other side of the table. But it has $732 million in cash on hand, with zero debt, and analysts are projecting 16% revenue growth. This year, though, Varonis has come back to earth — its stock price has sunk over 57% in the last 12 months. However, with strong projected 2023 revenue growth of 18.6%, Zuora remains a strong target for PE firms. Its stock price has been hammered, going down about 40% this year and making it the subject of mergers-and-acquisitions chatter.

Funding raised: $27 millionNumber of employees: 20Why it's set to take off next year: Provider burnout is getting worse, and it's exacerbating healthcare's staffing crisis. Nof said he expected Abridge's technology to be in demand next year as hospitals worked to reduce the administrative burdens on doctors. "They've reached a tipping point where people are desperate to gain efficiencies in their workday with all the physician burnout," he said. Abridge's technology takes the audio from doctor-patient interactions and automatically turns it into documentation for billing purposes or a summary of the visit for the patient. That means doctors are relieved of the "hours of pajama time in the evening that they previously spent doing clinical documentation," Cheatham said.

☆ Here are the 34 tech companies most likely to be on the holiday shopping lists of private-equity firms after valuations plunged this year, according to bankers and private data
▼ + stars: | 2022-12-15 | by ( Ben Bergman | Stephanie Palazzolo | ) www.businessinsider.com time to read: +22 min

Search resuls for: "Healthcare's"

25 mentions found